WAM
CMD

Wealthspire Advisors (Maryland)’s Cantel Medical Corporation CMD Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-414
Closed -$28K – 2351
2019
Q1 		$28K Buy
414
+232
+127% +$17.6K ﹤0.01% 1145
2018
Q4 		$14K Buy
182
+168
+1,200% +$13.9K ﹤0.01% 1359
2018
Q3 		$1K Sell
14
-5
-26% -$476 ﹤0.01% 2357
2018
Q2 		$2K Sell
19
-1
-5% -$112 ﹤0.01% 2239
2018
Q1 		$2K Sell
20
-26
-57% -$2.91K ﹤0.01% 2257
2017
Q4 		$5K Buy
46
+26
+130% +$2.59K ﹤0.01% 1864
2017
Q3 		$2K Hold
20
– – ﹤0.01% 2031
2017
Q2 		$2K Buy
+20
New +$1.5K ﹤0.01% 2032

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s CMD Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 414 shares — an estimated $28K sold.

Wealthspire Advisors (Maryland) first reported a position in CMD in Q2 2017 and held it in 8 quarters. The position peaked at $28K in Q1 2019. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 414 Cantel Medical Corporation shares in Q2 2019, an estimated $28K.
  • Wealthspire Advisors (Maryland) first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Cantel Medical Corporation position peaked at $28K in Q1 2019.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.